BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29232183)

  • 21. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
    Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
    Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
    Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
    Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive decline in association with hyposmia in idiopathic rapid eye movement sleep behavior disorder: a prospective 2-year follow-up study.
    Shin C; Lee JY; Kim YK; Nam H; Yoon EJ; Shin SA; Kim HJ; Jeon B
    Eur J Neurol; 2019 Nov; 26(11):1417-1420. PubMed ID: 31230396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
    Janzen A; Kogan RV; Meles SK; Sittig E; Renken RJ; Geibl FF; Booij J; Stormezand G; Luster M; Mayer G; Leenders KL; Oertel WH
    Mov Disord; 2022 Mar; 37(3):624-629. PubMed ID: 34796976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder.
    De Marzi R; Seppi K; Högl B; Müller C; Scherfler C; Stefani A; Iranzo A; Tolosa E; Santamarìa J; Gizewski E; Schocke M; Skalla E; Kremser C; Poewe W
    Ann Neurol; 2016 Jun; 79(6):1026-30. PubMed ID: 27016314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
    Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid eye movement sleep behavior disorder: A proof-of-concept neuroprotection study for prodromal synucleinopathies.
    Arnaldi D; Famà F; Girtler N; Brugnolo A; Pardini M; Mattioli P; Meli R; Massa F; Orso B; Sormani MP; Donegani MI; Bauckneht M; Morbelli S; Nobili F
    Eur J Neurol; 2021 Apr; 28(4):1210-1217. PubMed ID: 33275819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
    Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
    Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of multimodal imaging with
    Miyagawa T; Przybelski SA; Maltais D; Min HK; Jordan L; Lesnick TG; Chen Q; Graff-Radford J; Jones D; Savica R; Knopman D; Petersen R; Kremers WK; Forsberg LK; Fields JA; Ferman TJ; Allen L; Parisi J; Reichard RR; Murray M; Dickson D; Boeve BF; Kantarci K; Lowe VJ
    Neurobiol Aging; 2021 Mar; 99():11-18. PubMed ID: 33422890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
    Spiegel J; Hellwig D; Möllers MO; Behnke S; Jost W; Fassbender K; Samnick S; Dillmann U; Becker G; Kirsch CM
    Brain; 2006 May; 129(Pt 5):1188-93. PubMed ID: 16513685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
    Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
    Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.
    Sung YH; Kim JS; Yoo SW; Shin NY; Nam Y; Ahn TB; Yoo D; Lee KM; Kim HG; Koh SB; Kim J; Kim I; Kwon DY; Lee Y; Kim C; Chung SJ; Jo S; Lee SH; Kim SJ; Kim M; Lyoo CH; Baek MS; Kang SY; Chang SK; Jo SW; Lee SA; Ma HI; Kim YE; Kim ES; Kim YJ; Kim HS; Woo MH; Choi HJ; Kim EY
    Eur Radiol; 2022 May; 32(5):3597-3608. PubMed ID: 35064313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fate of patients with REM sleep behavior disorder and mild cognitive impairment.
    Arnaldi D; Chincarini A; De Carli F; Famà F; Girtler N; Brugnolo A; Pardini M; Massa F; Meli R; Schenone C; Bauckneht M; Morbelli S; Nobili F
    Sleep Med; 2021 Mar; 79():205-210. PubMed ID: 32451160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysprosody in Isolated REM Sleep Behavior Disorder with Impaired Olfaction but Intact Nigrostriatal Pathway.
    Rusz J; Janzen A; Tykalová T; Novotný M; Zogala D; Timmermann L; Růžička E; Šonka K; Dušek P; Oertel W
    Mov Disord; 2022 Mar; 37(3):619-623. PubMed ID: 34837250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.